Mohammed Al-Yahya1, Mohammad Raish2, Mansour S AlSaid1, Ajaz Ahmad3, Ramzi A Mothana1, Mohammed Al-Sohaibani4, Mohammed S Al-Dosari5, Mohammad K Parvez6, Syed Rafatullah7. 1. Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia ; Center for Medicinal, Aromatic and Poisonous Plants Research, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. 2. Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. 3. Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. 4. Department of Pathology, King Khalid University Hospital, King Saud University, Riyadh 11451, Saudi Arabia. 5. Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. 6. Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia . Electronic address: khalid_parvez@yahoo.com. 7. Center for Medicinal, Aromatic and Poisonous Plants Research, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Abstract
BACKGROUND/ PURPOSE: Ajwa, a special variety of Saudi Arabian dates (Phoenix dactylifera L.) is a rich source of nutrients, fibers and bioactive molecules. While previous studies have shown the therapeutic value of dates phytoconstituents in liver and kidney diseases etc., its cardioprotective potential remains elusive. We therefore, investigated the cardioprotective effect of lyophilized Ajwa extract (AJLE) ex vivo as well as in vivo. METHODS: Ex vivo cardioprotective effect of AJLE was evaluated on DCFH-toxicated cardiomyoblast cells (H9C2). In vivo hemodynamics, cardiac function, serum cardiac enzymes, myocardial antioxidant, inflammatory and apoptotic biomarkers as well as histopathological parameters were studied in IPS-injured Wistar rat heart tissues. RESULTS: AJLE (250 µg/ml) attenuated the cytotoxicity and enhanced the H9C2 proliferation by up to 40%. Oral administration of AJLE (250 and 500 mg/kg.bw) prevented the depletion of endogenous antioxidants (CAT, SOD, NP-SH and NO) and myocyte injury marker enzymes, and inhibited lipid peroxidation (MDA, MPO). Moreover, AJLE downregulated the expressions of proinflammatory cytokines (IL-6, IL-10 and TNFα) and apoptotic markers (caspase-3 and Bax), and upregulated the anti-apototic protein Bcl2. Histological data showed that AJLE pretreatment reduced myonecrosis, edema, and infiltration of inflammatory cells and restored the cardiomyocytes architecture. CONCLUSION: Taken together, our data revealed that AJLE had strong antioxidant, hypolipidimic, cardioprotective, anti-inflammatory and anti-apoptotic potential against myocardial damage. This further endorses the use of Ajwa in Arabian traditional medicine against cardiovascular diseases.
BACKGROUND/ PURPOSE: Ajwa, a special variety of Saudi Arabian dates (Phoenix dactylifera L.) is a rich source of nutrients, fibers and bioactive molecules. While previous studies have shown the therapeutic value of dates phytoconstituents in liver and kidney diseases etc., its cardioprotective potential remains elusive. We therefore, investigated the cardioprotective effect of lyophilized Ajwa extract (AJLE) ex vivo as well as in vivo. METHODS: Ex vivo cardioprotective effect of AJLE was evaluated on DCFH-toxicated cardiomyoblast cells (H9C2). In vivo hemodynamics, cardiac function, serum cardiac enzymes, myocardial antioxidant, inflammatory and apoptotic biomarkers as well as histopathological parameters were studied in IPS-injured Wistar rat heart tissues. RESULTS:AJLE (250 µg/ml) attenuated the cytotoxicity and enhanced the H9C2 proliferation by up to 40%. Oral administration of AJLE (250 and 500 mg/kg.bw) prevented the depletion of endogenous antioxidants (CAT, SOD, NP-SH and NO) and myocyte injury marker enzymes, and inhibited lipid peroxidation (MDA, MPO). Moreover, AJLE downregulated the expressions of proinflammatory cytokines (IL-6, IL-10 and TNFα) and apoptotic markers (caspase-3 and Bax), and upregulated the anti-apototic protein Bcl2. Histological data showed that AJLE pretreatment reduced myonecrosis, edema, and infiltration of inflammatory cells and restored the cardiomyocytes architecture. CONCLUSION: Taken together, our data revealed that AJLE had strong antioxidant, hypolipidimic, cardioprotective, anti-inflammatory and anti-apoptotic potential against myocardial damage. This further endorses the use of Ajwa in Arabian traditional medicine against cardiovascular diseases.
Authors: Mohammad Raish; Ajaz Ahmad; Mushtaq Ahmad Ansari; Khalid M Alkharfy; Abdul Ahad; Altaf Khan; Naushad Ali; Majid A Ganaie; Mohammed Abbas Ali Hamidaddin Journal: 3 Biotech Date: 2019-03-23 Impact factor: 2.406
Authors: Abdelaaty A Shahat; Mansour S Alsaid; Syed Rafatullah; Mohammed O Al-Sohaibani; Mohammad K Parvez; Mohammed S Al-Dosari; Vassiliki Exarchou; Luc Pieters Journal: BMC Complement Altern Med Date: 2016-09-08 Impact factor: 3.659
Authors: Reem A Al-Alawi; Jawhara H Al-Mashiqri; Jawaher S M Al-Nadabi; Badria I Al-Shihi; Younis Baqi Journal: Front Plant Sci Date: 2017-05-23 Impact factor: 5.753
Authors: Mohammad Raish; Mudassar Shahid; Yousef A Bin Jardan; Mushtaq Ahmad Ansari; Khalid M Alkharfy; Abdul Ahad; Ibrahim Abdelsalam Abdelrahman; Ajaz Ahmad; Fahad I Al-Jenoobi Journal: Front Pharmacol Date: 2021-02-25 Impact factor: 5.810